Top Doctor Top Doctor
The Top Doctor award is a peer-nominated award for providers who give exceptional care.

K. Scott Baker, MD, MS

Seattle Cancer Care Alliance
Professor, Department of Pediatrics
University of Washington School of Medicine
UW Medicine
Director, Survivorship Program; Director, Pediatric Blood and Marrow Transplant Program
Fred Hutchinson Cancer Research Center
Medical Oncology
“At SCCA and Fred Hutch, you’re in some of the best hands in the world. I don’t think you could be in a better place to receive a transplant. ”
— Dr. Baker
What makes working in transplant medicine meaningful for you?

I’ve been practicing medicine long enough now to be able to follow patients for 15 to 20 years after their blood or bone marrow transplant, and what always brightens my day is getting cards and letters from people I’ve treated. For example, one spring I received a high school graduation announcement for a boy I had transplanted when he was 15 months old. Along with the announcement, his mother had included a picture of him as a toddler, around the time of his transplant, and a current photo. Looking at him now, you would never know that he had been sick a day in his life. What a reward it is to see these kids growing up and reaching milestones. 

What’s it like to work with you?

My goal is to provide information and guidance to help you make the best decisions possible, both for your child and your family. Part of that process also involves learning from you; each family has something to teach me about their priorities and what they’ve been through. I also hope to offer peace of mind. Facing the need for a blood or bone marrow transplant is a stressful situation. The treatment is intense, complex and does not come without risk. But at SCCA and Fred Hutchinson Cancer Research Center, you’re in some of the best hands in the world. I don’t think you could be in a better place to receive a transplant. 

Provider background

Specialty: Medical Oncology

Malignant and non-malignant blood disorders

I am a hematologist-oncologist who specializes in pediatric blood and bone marrow transplantation. My primary clinical focus is using transplant to treat children and young adults with non-malignant blood disorders, such as bone marrow failure syndromes, primary immunodeficiencies and histiocytic disorders. I also treat patients with cancers such as acute myeloid leukemia. In addition to providing care, I direct the Survivorship Program and the Pediatric Blood and Marrow Transplant Program at Fred Hutch. 

My research is focused on better understanding the long-term health effects of transplantation. I have led studies investigating the effects of childhood cancer treatment on the heart, lungs, kidneys, hormones and reproductive system. At Fred Hutch and Seattle Children’s, I lead participation in the Childhood Cancer Survivor Study. This multi-institutional study tracks the health outcomes of childhood cancer survivors. I also lead clinical trials investigating the use of transplantation in young patients with non-malignant conditions. 

Diseases treated

Education, experience and certifications
Medical Degree
University of Nebraska
University of Nebraska Medical Center, Pediatrics
Children's Hospital Medical Center, Cincinnati, Pediatric Hematology-Oncology
Board Certification
Pediatric Hematology-Oncology, 1994, 2016, American Board of Pediatrics
MS, Clinical Research, University of Minnesota
Seattle Met's 2021 Top Doctors Award

Dr. Baker has been recognized as a Top Doctor in this peer-nominated award.


“Scott has been delightful to work with and learn from. He has had an interest in survivorship for many years and was part of the Livestrong grant that originally brought survivorship care to SCCA. He has deep passion for this area of care and a deep research interest. It’s a pleasure for me to be able to work side by side with him.”
— Jennie Crews, MD, MMM, FACP
“Dr. Baker is a pioneer in pediatric cancer survivorship. He has done so much to enhance our understanding of the effects of blood and marrow transplantation on children and young adults. I admire the way he has advanced the science of the field. ”
— Neel Bhat, MBBS, MPH


Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
Complete title
Off-label Clinical Treatment Use of the CliniMACS(R) CD34 Reagent System
Study ID:
Complete title
Cancer Survivorship: A Multicenter Study to Assess Late and Long-term Effects of Cancer Treatment and to Improve and Expand Care Among Cancer Survivors
Study ID:
Complete title
Evaluation of Late Effects of Pediatric Hematopoietic Stem Cell Transplantation


Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Team coordinator (TC)
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.


SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For providers